Integral Diagnostics Limited (ASX:IDX – Get Free Report) insider Raelene Murphy purchased 15,000 shares of the business’s stock in a transaction on Tuesday, March 11th. The stock was bought at an average cost of A$2.36 ($1.48) per share, for a total transaction of A$35,400.00 ($22,264.15).
Integral Diagnostics Stock Performance
The company has a debt-to-equity ratio of 118.59, a quick ratio of 1.84 and a current ratio of 0.86. The stock has a market capitalization of $1.10 billion, a PE ratio of -11.45, a price-to-earnings-growth ratio of 1.39 and a beta of 0.73.
Integral Diagnostics Dividend Announcement
The company also recently announced a Interim dividend, which will be paid on Sunday, April 6th. Shareholders of record on Sunday, April 6th will be issued a dividend of $0.025 per share. This represents a yield of 1.06%. The ex-dividend date of this dividend is Wednesday, March 5th. Integral Diagnostics’s dividend payout ratio (DPR) is presently -23.08%.
Integral Diagnostics Company Profile
Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.
Further Reading
- Five stocks we like better than Integral Diagnostics
- What is the Australian Securities Exchange (ASX)
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- About the Markup Calculator
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- Top Stocks Investing in 5G Technology
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Integral Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
